Status:
WITHDRAWN
Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Locally Advanced Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies information from a home sleep apnea machine to evaluate obstructive sleep apnea in patients with stage III-IV head and neck cancer. Sleep apnea (trouble breathing during sleep) can ...
Detailed Description
This is a single center study in HNSCC subjects to assess the effects of CRT on OSA.. Patients will be screened with a physical exam and questionnaire (The Berlin questionnaire, STOP-BANG, PSQI) and w...
Eligibility Criteria
Inclusion
- Locally advanced (stage III-IVb) and metastatic (stage IVc) HNSCC who are referred to medical oncology. Patients may not have received upfront definitive surgical resection of the primary tumor or upfront neck dissection.
- Patients must be able to operate the home sleep study device.
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
Exclusion
- Patients should not have received any prior systemic chemotherapy or radiation therapy for locally advanced or metastatic HNSCC.
- Patients with tracheostomy or those requiring the assistance of a ventilator will be ineligible for the study.
Key Trial Info
Start Date :
July 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03875053
Start Date
July 25 2023
End Date
August 24 2024
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States, 48201